,12,13 These methods notably highlighted major tumor-stoma and tumor-immune interactions,14,15,16 interactions modulated when exposed to PD-1 blockade17,18 or upon VHL mutation,19 and molecules potentially driving tumor progression.16 This evidence concerns the gene VHL and neoplasm.